Completed PHASE3 INTERVENTIONAL 2-arm NCT01115504

Thiamine Supplementation in Heart Failure Patients Receiving Full Medical Therapy

Sponsor: Mashhad University of Medical Sciences

Interventions Thiamine

Updated 6 times since 2017 Last updated: Dec 22, 2010 Started: May 31, 2010 Primary completion: Nov 30, 2010 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01115504, this PHASE3 trial focuses on Chronic Heart Failure and remains completed. Sponsored by Mashhad University of Medical Sciences, it has been updated 6 times since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mashhad University of Medical Sciences

Data source: Mashhad University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shahrood, Iran